by Raynovich Rod | Feb 1, 2018 | Biopharmaceuticals, Macro
Profit Taking Hits Biotech Stocks Disruption Coming to Healthcare? Another Round of Sector Rotation? The biotech sector hit a wall after breaking through to new highs last week. The major news that sparked profit taking on Tuesday was that Amazon, Berkshire Hathaway...
by Raynovich Rod | Jan 28, 2018 | Biopharmaceuticals, Weather Snow Reports West Coast
Update-2 Weather.com Confirms Warm Dry Outlook for February Finally recognition of drought conditions. Look for changes in five days or State needs to announce conservation measures. Update-1 Monday 1/29 Skied Mammoth today and snow conditions were OK. Plenty of...
by Raynovich Rod | Jan 26, 2018 | Biopharmaceuticals
Update-1 10:40am EST, NASDAQ off 0.75%, S&P 500 off 0.82% Caution in biotech and healthcare stocks with disruptive announcement from J.P.Morgan, Amazon and Berkshire Hathaway with XLV down 2%. The three companies announced Tuesday that they would form an...
by Raynovich Rod | Jan 22, 2018 | Biopharmaceuticals
Update-1 Jan 23, 2018… Biotech Breakout Rally Continues The biotech rally cruised on to the second day with the smaller cap, equal weighted XBI moving up 2% to $95.82 a 12 month high. The large cap weighted IBB followed up 1.12% to $116.81 also a 12 month high....
by Raynovich Rod | Jan 16, 2018 | Biopharmaceuticals
Update-1… January 17 Dow Rallies 300 Points Market returns to the momentum mode with tax reform theme, M&A and upbeat earnings. Apple (AAPL)was a driver as a potential job creator up 1.6% on repatriation of foreign cash and contributing $350B to economy. ...
by Raynovich Rod | Jan 15, 2018 | Biopharmaceuticals
Large Cap Biopharmaceuticals 2018 Performance after J.P.Morgan Healthcare Conference Here is an update of Large Cap Biopharmaceuticals Performance over the past 12 months. These numbers will be updated after all 2017 financials have been reported. Note that the IBB...
by Raynovich Rod | Jan 12, 2018 | Biopharmaceuticals
J.Morgan Healthcare Conference: Companies to Watch We are still reviewing 2018 J.P.Morgan Healthcare presentations for inclusion in our portfolio but here are two longer term opportunities to track for milestones and growth: Accelerate Diagnostics and Denali...
by Raynovich Rod | Jan 10, 2018 | Biopharmaceuticals
Sluggish Early Trading in Biotech Tracks NASDAQ Down 0.14%% Promising Year for M&A and Tax Cuts Improving Bottom Line There is a little follow-on to Tuesday’s rally bringing prices for major ETFs above where they were last week. The biotech screen reverted...
by Raynovich Rod | Jan 9, 2018 | Biopharmaceuticals
Weak Start for Biotech Stocks on 1/8/18-Red Screen Day Positive Updates on BIIB CELG GILD etc Biotech ETFs Firm Up about 1.5% Tuesday AM JPMorgan Healthcare Conference Biotech stocks abruptly sold off at the market open yesterday with the XBI down 2% to the $85.31...
by Raynovich Rod | Jan 4, 2018 | 2024-25 Life Science Portfolios, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Biotech ETF Performance Updates as of 4/11/18 YTD FBT First Trust NYSE Arca Biotech ETF is the leader in 2018. FBT up 7.45% Top Five Holdings are: AVXS, NKTR, XON, AGIO, TECH. The holdings are quite different than the large cap weighted FBIOX and IBB. XBI up 3.75% at...
